Budget impact assessment of AprokamĀ® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis
Crossref DOI link: https://doi.org/10.1186/s12886-015-0056-5
Published Online: 2015-07-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Purslow, Christine
Davey, Keith
Johnson, Mildred
Pietri, Guilhem
Suri, Gaurav
License valid from 2015-07-08
Article History
Received: 12 January 2015
Accepted: 12 June 2015
First Online: 8 July 2015